ArticleBlood advances2023

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.

Elisa Gelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.